Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
REYKJAVIK, Iceland, June 4, 2026 - Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide,...
-
Alvotech (NASDAQ: ALVO, ALVO SDB) tilkynnti í dag að fyrirtækið hafi lagt inn að nýju til Matvæla- og lyfjastofnunar Bandaríkjanna (FDA) umsóknir um leyfi til markaðssetningar í Bandaríkjunum á...
-
The 2026 Annual and Extraordinary General Meeting of Alvotech (the "2026 AGM") was held on June 3, 2026, at Arendt House, 41A Avenue John F. Kennedy, L-2082 Luxembourg. All of the draft resolutions...
-
Aðalfundur Alvotech fór fram 3. júní 2026. Fundurinn var haldinn í Lúxemborg, á skrifstofu lögfræðistofunnar Arendt við Avenue John F. Kennedy 41A. Allar tillögur á dagskrá fundarins voru...
-
REYKJAVÍK, Iceland and LUXEMBOURG, June 03, 2026 (GLOBE NEWSWIRE) -- The 2026 Annual and Extraordinary General Meeting of Alvotech (the "2026 AGM") was held on June 3, 2026, at Arendt House,...
-
REYKJAVIK, ICELAND (June 2, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for...
-
REYKJAVÍK 2. JÚNÍ 2026 – Alvotech tekur þátt í þremur fjárfestaráðstefnum í Bandaríkjunum fyrri hluta júnímánaðar. Þar munu Róbert Wessman, stjórnarformaður Alvotech og Balaji V. Prasad,...
-
Alvotech (NASDAQ US: ALVO, ICELAND: ALVO, STOCKHOLM: ALVO SDB) Financial Highlights A supplemental long‑form earnings release providing additional operational details and business update for Q1...
-
Alvotech (NASDAQ US: ALVO, ÍSLAND: ALVO, STOKKHÓLMI: ALVO SDB) Helstu niðurstöður Ítarlegri tilkynning á ensku sem veitir nánari upplýsingar um fjárhag og rekstur á fyrsta ársfjórðungi 2026 er birt...
-
REYKJAVIK, ICELAND (April 24, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for...